Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803452 · ClinicalTrials.gov registry record · Phase 4
Lipids of the Human Tear Film and Their Effect on Tear Stability
A Phase 4 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT00803452 is a Phase 4 study that has completed, run by University of Louisville. The registered enrollment target is 31 participants.
The verdict
NCT00803452, a Phase 4 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This prospective, randomized, comparative clinical trial evaluates the effect of either oral doxycycline, oral essential fatty acid, or topical azithromycin to modify the secretions of the meibomian gland in subjects with meibomian gland dysfunction and/or dry eye disease.
Interventions
- DRUG azithromycin
- DRUG doxycycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00803452
The ClinicalTrials.gov registry entry for NCT00803452 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which azithromycin is the first listed.
NCT00803452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00803452 about?
NCT00803452 is a clinical study titled "Lipids of the Human Tear Film and Their Effect on Tear Stability". This prospective, randomized, comparative clinical trial evaluates the effect of either oral doxycycline, oral essential fatty acid, or topical azithromycin to modify the secretions of the meibomian gland in subjects with meibomian gland dysfunction and/or dry eye disease.
What is the current status of trial NCT00803452?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2008-07. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00803452?
The interventions under investigation include: azithromycin (DRUG), doxycycline (DRUG).
Who is sponsoring clinical trial NCT00803452?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.